Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Recordati S.p.A. has updated its ongoing share buyback program, purchasing 63,381 shares between October 28 and November 1, 2024, at an average price of €53.1691. This initiative supports the company’s stock option and incentive plans, enhancing value for shareholders. Recordati, a global pharmaceutical group, remains committed to addressing both common and rare health challenges.
For further insights into IT:REC stock, check out TipRanks’ Stock Analysis page.